Researchers analyzed 10 biomarkers associated with biological aging among a group of HIV-positive and -negative Europeans.

The U.S. Preventive Services Task Force has reaffirmed its 2009 recommendation.

Cabometyx is the third liver cancer drug approved in the past six months.

More than 3,000 patients have been warned that they may have been exposed to blood-borne pathogens at the facility.

In an analysis of the liver health of a cohort of HIV/hep B–coinfected people, one third had significant fibrosis.

Nearly 3,800 patients at the New Jersey surgery center may have been exposed, though the risk of infection is low.

A closer look at hepatitis B immunization, and what you can do if you aren’t immune after receiving the series of shots.

A light-hearted look at serious issues, such as the rise in hepatitis cases, the opioid epidemic and fatty liver disease.

Here are the treatment news stories on Hep with the most views this year

The FDA’s revision was based on two randomized trials of Viread (tenofovir disoproxil fumarate) use in 2- through 11-year-olds.